background: Neural tube defects (NTDs) are severe abnormalities of the central nervous system that occur as a result of abnormal development in the third and fourth weeks of gestation. Studies have shown that periconceptional folic acid (FA) can reduce both the incidence and recurrence of NTDs. conclusions: Social, demographic and economic factors have an important influence on the FA uptake. Vulnerable groups who report limited uptake of FA need to be specifically targeted in future Public Health campaigns and further consideration needs to be given to the debate on food fortification in countries where this is currently not available.
Introduction
Neural tube defects (NTDs) refer to a cluster of neurodevelopmental conditions, including anencephaly and spina bifida associated with failure of neural tube closure during embryonic development (Beaudin and Stover, 2009) . NTDs constitute an important public health problem in terms of mortality, morbidity, social cost and human suffering (Kirke et al., 2004) . Ireland has currently one of the highest incidences of NTDs in Europe, affecting approximately 1-1.5 per 1000 total births nationally (National Committee on Folic Acid food fortification, 2006). The rate is higher again in Hungary, with an incidence of isolated NTD in 2.8 per 1000 births, a rate that has been confirmed in an intervention trial (Czeizel and Dudas, 1992) . Some of the variation in national rates will be accounted for by differences in prenatal diagnostic screening policies, access to termination of pregnancy and expert post-mortem examination following fetal loss. Currently in Ireland there is no routine national screening programme and termination of pregnancy is not legal. The worldwide prevalence of NTDs ranges from approximately 0.05 to 6 per 1000 births, with regional and population-specific variation in prevalence (Beaudin and Stover, 2009) .
Robust evidence has accumulated over the last 30 years to show that supplementation with folic acid (FA) prior to and during early pregnancy, significantly reduces the risk of first and recurrent NTDs in the developing fetus (MRC, 1991 , Berry et al., 1999 RyanHarshman and Aldoori, 2008) . Although, the exact mechanisms resulting in failure of neural tube closure are unknown (Dunlevy et al., 2007) , up to 70% of NTDs can be prevented by maternal FA supplementation (Beaudin and Stover, 2009) . FA supplementation may also have a role in reducing the incidence of cardiovascular and urinary tract congenital anomalies and some types of cleft palate (Czeizel, 2009; Ionescu-Ittu et al., 2009) .
Since the emergence of good evidence in the early 1990s that FA taken periconceptionally can reduce the incidence of NTDs, many countries have advocated periconceptional FA supplementation. However, the uptake levels are still low, and although the incidence of NTDs initially decreased significantly, rates are now seen to be levelling off, particularly in Ireland and the UK (Murphy et al., 1996) . There is still considerable scope for improving FA uptake, with potentially preventable NTDs cases occurring each year.
Previous studies have shown that sociodemographic variables influence periconceptional FA uptake. Stockley and Lund (2008) carried out a systematic review of the relevant research to provide a basis for making recommendations on the potential to improve the use of FA supplements in the UK, particularly among low-income and young women. Study quality was often poor with many small interviewer-led questionnaire studies often late in pregnancy or even after delivery with a high risk of recall bias. The aim of this study is to determine the prevalence and predictors of FA uptake in a large population-based obstetric cohort with systematic ascertainment of FA exposure at the booking visit.
Materials and Methods
This study was carried out using the records of all women with antenatal and delivery records in the Coombe Women and Infants University Hospital between 1 January 2000 and 31 December 2007. There were 62 063 deliveries recorded during the study period; however, antenatal questionnaires were missing for 811 (1.3%) either because the woman had booked elsewhere and was transferred to the hospital for delivery or had arrived unbooked in late pregnancy, leaving a total of 61 252 records suitable for analysis.
The database contained obstetric, medical and sociodemographic information. Information on the FA uptake was recorded electronically using a computerized antenatal questionnaire by midwives at the patient's first antenatal visit, which usually occurred at about 12 week's gestation. Two questions concerning the FA usage are included in the booking questionnaire:
(1) Have you taken FA and which preparation? (2) For how long have you been taking FA? (pre-/post-conception) Recommended FA uptake for the prevention of first occurrence of NTD-affected births is defined as taking FA 400 mg each day starting preconception and continuing until the end of the first trimester (National Institute for Health and Clinical Excellence, 2008) . For the purposes of this study the recommended approach to FA uptake was defined as taking FA pre-and post-conception as stated above and nonrecommended FA uptake was defined as post-conception only, taken intermittently, not taken and all other answers.
In addition to FA use, information on the following maternal characteristics was extracted from the electronic records: maternal age, parity, nationality, marital status, socio-economic status (SES; based on occupation), smoking, alcohol use, history of illicit drug use, planned pregnancy, fertility treatment received, referral to a social worker, gestation at booking and private or non-private antenatal care.
The analyses were performed using the Statistical Package for Social Sciences (SPSS w , version 15). Descriptive statistics were used to characterize the study subjects. Univariable comparisons were made between the characteristics of the recommended and non-recommended FA groups to identify predictors of FA uptake. Results are reported as odds ratios (OR) and 95% confidence intervals (CI) derived from binary logistic regression analyses. Further comparisons were made adjusting for potential confounding factors using multivariable logistic regression. Factors were included in the multivariable models based on a statistically significant difference between the two groups in the univariable analyses (P , 0.05) or if there was a biologically plausible potential for confounding. Further comparisons were made between women who had taken any FA supplements and women who had taken no FA but excluded women who had reported 'don't know' about FA uptake. Results are reported as unadjusted and adjusted ORs with 95% CI. A separate analysis was carried out using only the first occurring pregnancy from each individual woman in the cohort. The results of this analysis were only marginally different from the results of the analysis using the entire cohort therefore all pregnancies were used in the final analysis and assumed to be independent events for the multivariable logistic regression. The study received the approval of the Coombe Women and Infants University Hospital's research ethics committee.
Results
The characteristics of the women in the cohort are presented in Table I . Only 17.5% of women booked for care at less than 12 weeks gestation and 11.6% booked at more than 20 weeks gestation with the majority booking between 12 and 20 weeks gestation. A third of all women reported at booking that the pregnancy was unplanned. A total of 1326 women (2.2%) had conceived following fertility treatment. A third of women were single, a fifth were current smokers and more than 1 in 10 required referral to a social worker. The SES reported by women reflects the diverse population attending the hospital. A total of 1410 women (2.3%) reported taking multi-vitamins, of whom most, 1187 (84%), took additional FA supplements.
Of the 61 252 women in the cohort, 61 056 had data recorded on FA supplementation. Of these 85% reported taking FA at some point during the periconceptional period; however, only 28% took FA both pre-and post-conception as recommended. Figure 1 shows the increase in the rate of recommended uptake of FA during the 8 years of the study from 17% in 2000 to a peak of 36% in 2006. Factors associated with recommended FA uptake included nulliparity adjusted OR: 1.35 (95% CI: 1.28 -1.43), early booking (,12 weeks) OR: 1.24 (95% CI: 1.17 -1.31), private health care OR: 4.32 (95% CI: 4.1-4.6) and fertility treatment OR: 2.88 (95% CI: 2.44-3.40). (Table II ) However, even among women who conceived following fertility treatment only 79% achieved recommended FA uptake and only 41% of those who stated that the pregnancy was planned reported recommended FA use.
The vast majority of the women in the non-recommended group had only started taking FA when they realized they were pregnant or had booked at later than 12 weeks gestation and had not taken any FA supplements. Periconceptional folic acid uptake than those from Western Europe and the highest uptake was among women from North America, Australia and New Zealand. The results were similar for the comparisons between women who had taken no FA supplements and women who had taken any FA (Table III) .
Discussion
We found a low uptake of the recommended approach to periconceptional FA among women booking for obstetric care. FA uptake was associated with increasing maternal age, planned pregnancy, early booking and private health care. Less than recommended or no FA uptake was associated with women from lower socio-economic groups, immigrants from low-income countries, smokers and women who required intervention from a social worker. Although the uptake of recommended FA increased over time the population coverage was poor and strongly influenced by social, demographic and economic factors.
The population consisted of a complete geographical cohort of women attending for booking at a large urban maternity hospital. The data were collected prospectively and ascertained routinely by a qualified midwife using a structured electronic database with a prompt for each data item. There was very little missing data and interpreters were used where the woman had any difficulty understanding English. The data on periconceptional FA uptake relied on self-reporting and recall and it is certainly possible that women may over-estimate Continued their use of FA however it is very unlikely that they would underestimate FA use. Recall may pose particular difficulty for women who booked late. If anything the true rate of recommended FA uptake may be lower than reported here. The challenge with an observational study lies in the potential for confounding when evaluating individual risk factors or predictors of FA uptake. We have attempted to control for this by performing multivariable logistic regression analyses adjusting for relevant factors; however, there may still be residual confounding and the results should be interpreted accordingly. Stockley and Lund (2008) performed a systematic review of the literature to provide a basis for making recommendations on the potential to improve the use of FA supplements in the UK, particularly among low-income and young women . In keeping with our study they found the factors most associated with lower FA use were unplanned pregnancy, lower age, SES and ethnicity. Women having a planned pregnancy, being married, of older age and of higher SES were found to be more likely to take recommended periconceptional FA. Many of the studies addressing the determinants of FA use involved small interviewer-led questionnaire studies often late in pregnancy or even after delivery, and thus suffering from a high risk of recall bias. Some studies adjusted for potential confounders (Cleves et al., 2004; Carmichael et al., 2006; Goldberg et al., 2006) ; however, most studies reported the frequency of FA uptake by univariate analysis of maternal characteristics.
Women who had assisted conceptions or attended fertility clinics were found to have a higher uptake of recommended FA, but as with our study the uptake was disappointing considering the greater contact with health-care professionals and opportunity to reinforce the need for periconceptional FA (Rimm et al., 2004; Hansen et al., 2005; Ludwig et al., 2006) . Previous Irish studies have reported periconceptional FA uptakes of between 6 and 25% (Milner et al., 1996; Sayers et al., 1997; McDonnell et al., 1999; O Leary et al., 2001; Ward et al., 2004) . Our study shows improvement but there is a long way to go yet. International studies have shown similarly poor rates of recommended FA use at 22.7% (Cleves et al., 2004 ) but also higher rates of FA use of 50 and 53% (Neill et al., 1999; Carmichael et al., 2006) . It has been suggested that folate intake among women of child-bearing age in America (where flour is fortified) may have reached levels where nearly all folate-sensitive NTDs have been prevented (Mosley et al., 2009) . FA fortification of flour is due to be introduced in Australia and New Zealand in September 2009 (Bower et al., 2009 ) and it will be interesting to follow the effect of fortification on NTD prevalence in these areas. Schorah (2009) argues that fortification is the only way to target vulnerable groups of women 'A significant number of pregnancies are unplanned, and without mandatory food fortification, the syndrome of disadvantage guarantees that those who require folate the most will be the least likely to receive it, fetuses that need not be affected by NTD will continue to be affected'. However, the contrary view is that there is a 'floor effect' for folic-acid preventable NTDs and that it may not be possible to prevent all NTDs particularly in counties with NTD prevalence close to the observed floor (Heseker et al., 2009) . Our study reinforces the association between low uptake of FA and social, demographic and economic disadvantage. Public health campaigns need to educate and change attitudes towards pregnancy and promote healthy lifestyle choices in women of child-bearing age. An ideal approach would incorporate advice on diet, exercise, alcohol, smoking, drugs and FA supplementation as part of a pre-pregnancy planning strategy. Primary prevention of NTDs by periconceptional FA intake is a major public health opportunity for all the multidisciplinary health-care team. Future campaigns need to be cognizant of the growing ethnic population of Ireland and pay special attention to language, cultural barriers and illiteracy. The role of FA fortification of flour in countries where this is not available requires further debate since it may not reach the most vulnerable women at the present time.
